Home › Leukemia › NCT06907797

Tools for Reducing Inequity in Acute Leukemia (TRIAL): Beta Testing

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* Age 18 or older
* English speaking
* Ability to understand and willingness to sign written informed consent
* Clinical suspicion of acute leukemia
* Admitted to DFCI-affiliated inpatient unit

Exclusion Criteria:

* Cognitive impairment rendering the individual unable to participate in beta testing

  * This will be assessed by focused chart review and consultation with the patients' inpatient care team.
* The following populations will be excluded: adults unable to consent, individuals who are not yet adults (infants, children, teenagers \<18 years old), prisoners.
* Inability to participate in in-person application testing.
* Patients who participated in alpha-testing through protocol 23-404 (Appendix A)

About the study

This study aims to test the Tools for Reducing Inequity in Acute Leukemia (TRIAL) web-based application that is designed to support participants with acute leukemia by providing information and resources about leukemia and clinical trial participation.

What is being tested

• TRIAL Web-Based Application (behavioral)

Sponsor: Dana-Farber Cancer Institute · Participants: 75 · Started: Apr 1, 2025

Contact the study team

• Andrew Hantel, MD · Phone: 617-582-9394
• Oldy S Bejarano, MPH · Phone: 857-215-2365

Official record on ClinicalTrials.gov — NCT06907797

Locations in the U.S.

Conditions

• Leukemia

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.